We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shield Therapeutics Plc | LSE:STX | London | Ordinary Share | GB00BYV81293 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.925 | 1.80 | 2.10 | - | 0.00 | 07:32:22 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 4.47M | -40.44M | -0.0522 | -0.37 | 14.89M |
Date | Subject | Author | Discuss |
---|---|---|---|
04/3/2019 07:45 | best1467 yes this potentially can be a big number Company, I am holding large quantities of stock and added on the pull back. Fab news today, should really start to see the share price motor now. GLA long term holders | ny boy | |
04/3/2019 07:37 | Just looked at fern jet growth rate 2016 162 million 2018 762 million amazing growth and shield have a superior product because no need to go to hospital with the correct team in place this is potentially the most undervalued share I’ve ever invested in. This is based on facts no hype let’s see where we are by year end with the right result with FDA which I can’t see any reason we will not get to £3.50 and that maybe conservative exciting. | best1467 | |
04/3/2019 07:32 | Shield Therapeutics PLC Positive results for Feraccru® in AEGIS-H2H study and a €2.5M milestone payment from Norgine BV Fantastic news! Should be up 20%+ on that news alone, re rating due soon, broker revised numbers etc | ny boy | |
04/3/2019 07:14 | Onwards an upwards ahead of FDA approval. | nobbygnome | |
04/3/2019 07:12 | The market potential is getting larger great result from a tough and complex trial | best1467 | |
01/3/2019 10:44 | No MSYS on that list | knowing | |
01/3/2019 10:43 | Steady as she goes here, ready for the next leg up, investors buying elsewhere, so pays to have a diverse portfolio. Good to see IDP,AOR & PFC going well. | ny boy | |
26/2/2019 09:48 | Morning Wuzy, welcome aboard! Probably a thousand + lurkers behind the scene. Steady as she goes, not many sellers, most are holding for FDA news late July/early August this year. Recent broker upgrade is supportive. GL all | ny boy | |
22/2/2019 09:01 | Hi ny boy, no I've bought more so that's at least 3 of us,cheers | wuzy | |
22/2/2019 08:56 | Yes, there must be plenty in the background driving the price higher. Strong bounce so far. Testing the prior high area. | cf456 | |
21/2/2019 23:34 | Surely not just the two of us moving the share price higher, must be thousands of secret lurkers about lol! Heading for a breakout again imo | ny boy | |
20/2/2019 16:10 | Yes, a significant broker upgrade target yesterday. Over double the current share price. Last move up was very rapid once it got going. I wonder if this one will be the same. | cf456 | |
20/2/2019 16:02 | cf456..good find, so a nice mugging from 60p to 46p to relief weak holders, then a big broker upgrade lol! Anyway it was a good opportunity to acquire more. | ny boy | |
20/2/2019 15:55 | Continuing the move back up. | cf456 | |
19/2/2019 22:05 | Liberum Capital upping its target price for the shares today. A significant uplift as well. From 80p to 116p. Target now more than 2x the current share price. --- "Liberum Capital today reaffirms its buy investment rating on Shield Therapeutics Plc (LON:STX) and raised its price target to 116p (from 80p)." | cf456 | |
19/2/2019 15:57 | The recent CEO interview worth listening too as a reminder of the potential here: from 20:30 | cf456 | |
19/2/2019 14:55 | The prior move up was strong and fast so possibly profit takers from that. Could also have been an institutional buy order wanting filled at a lower price and the MMs pulling back for that. But yes, the story is still the same. Way undervalued and plenty of catalysts moving forwards. All that and a cheaper entry price here. | cf456 | |
19/2/2019 14:40 | Yeah topped up as it reached by buying zone, no real reason for the pull back, nothing has changed, lots to be positive about, roll on mid summer for FDA news out of the USA, that and a tie up with a licensing deal, zoom! | ny boy | |
19/2/2019 14:05 | Looks about ready to bounce now. | cf456 | |
15/2/2019 11:28 | Waiting patiently to add, reckon 46-48p area is possible but we will see | ny boy | |
13/2/2019 09:59 | 950k @ 54p, difficult to tell if a buy that was worked through from a while ago or a sell on the run up to 60p? Might not be a big enough stake to show up as a increase/decrease of holding. | ny boy | |
12/2/2019 09:12 | Just a hold now until excitement mounts as we get closer to FDA news and partner tie up | ny boy | |
11/2/2019 12:56 | Dropped the bid 1p despite L2 strong lol! | ny boy | |
11/2/2019 08:23 | Yes Vrs struggling needs some good news but am very confident, this one has a nice chart, not that l follow charts but even l can see the upward trend.cheers | wuzy | |
11/2/2019 08:14 | Welcome Wuzy, I am holding VRS too, best stay patient with that one! Good start to the week here after a nice pull back, which has encouraged investors to either come in or add. GL | ny boy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions